Page last updated: 2024-11-03

procarbazine and Eaton-Lambert Myasthenic Syndrome

procarbazine has been researched along with Eaton-Lambert Myasthenic Syndrome in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Homenda, W1
Hellmann, A1

Other Studies

1 other study available for procarbazine and Eaton-Lambert Myasthenic Syndrome

ArticleYear
[Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2000, Volume: 53, Issue:9-10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Humans; Lam

2000